OasisLMS

The ASNC2024 Annual Scientific Session and Exhibition Meeting OnDemand course will provide you with top-notch education from thirty-one sessions recorded during the live / virtual meeting September 5-7, and September 14, 2024.

ASNC2024 set a new benchmark for nuclear cardiology with cutting-edge content, packed sessions, and high energy. The sessions provided shared valuable insights on disease-based tracks, radiopharmaceutical innovations, and new diagnostic techniques that every nuclear cardiology professional needs to know.

ASNC2024 Meeting OnDemand offers 31 sessions highlighting how nuclear cardiology is expanding rapidly across amyloidosis, artificial intelligence, hybrid imaging, infection, inflammation, molecular imaging, myocardial blood flow quantification, radiopharmaceuticals, sarcoid, and much more.

Earn up to 28.25 CME credits.

This online activity consists of OnDemand lectures recorded from the ASNC2024 sessions. In order to claim CME credits, you must listen to the recordings and then complete the Evaluation. You can claim credit as you progress through the activity, e.g., watch 2 sessions, claim credit, complete the evaluation, and receive your CME Certificate.  If you watch other presentations and claim credit after completing the evaluation, your CME Certificate will denote the additional credits. This course does not carry ABIM Maintenance of Certification (MOC) points.

This course is intended for cardiologists, radiologists, nuclear medicine specialists, nuclear technologists, nurses, practice administrators, and other health care professionals with an interest in the field of nuclear cardiology.

At the end of this activity, participants will:

• Demonstrate improved skills in image interpretation and reporting
• Recognize and minimize technical problems and artifacts that may be associated with cardiac imaging
• Identify appropriate use of cardiac imaging techniques based on current guidelines
• Evaluate new imaging technologies, software, and stress techniques
• Identify the role of nuclear and cardiac CT imaging in overall patient care
• Describe the importance of balancing radiation exposure with image quality
• Describe future directions in cardiac PET, CT, and SPECT/CT to anticipate training and equipment needs
• Identify the clinical implication of CT coronary angiography cases and recognize its value and limitations in clinical cardiology

This activity will increase learners’ competence in solving technical and clinical issues when treating patients with CVD. Sessions present different approaches to cardiac disease management to how to best improve patient outcomes. These sessions address topics in appropriate use criteria, SPECT best practices, PET best practices, new and emergent cardiac imaging procedures, lab performance and procedures, radiation safety, reporting, and lab performance and the application of appropriate guidelines-based treatments.

To maintain competence and improve performance, imaging professionals must assimilate and integrate knowledge spanning multiple areas, including clinical data, technical aspects of imaging, and appropriate application of imaging (e.g., clinical guidelines and appropriate use criteria). Each of these areas is constantly evolving, particularly as innovative technologies and novel pharmacologic agents are introduced. ASNC2024 is an educational activity designed to help imaging professionals on how to best improve outcomes for their patients with CVD.

Physicians: The American Society of Nuclear Cardiology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The American Society of Nuclear Cardiology designates this enduring activity for 28.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.



Physician Assistants: The American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by ACCME.

Nurse Practitioners: The American Academy of Nurse Practitioners Certification Board (AANPCP) recognizes attendance at continuing education offerings which provide AMA PRA Category 1 Credits™ for the purpose of recertification.

As an accredited provider of the Accreditation Council for Continuing Medical Education (ACCME), The American Society of Nuclear Cardiology (ASNC) adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. In compliance with these standards, it is ASNC’s policy to ensure balance, independence, objectivity, and scientific merit in all its educational activities through the disclosure of all financial relationship with ineligible companies and mitigation of conflicts of interest. The financial interest or relationships requiring disclosure are outlined in ASNC’s CME Conflict of Interest Policy. All planners, reviewers, and presenters involved with this activity were required to disclose all financial relationships. The American Society of Nuclear Cardiology has reviewed this activity’s faculty disclosures and mitigated all identified conflicts of interest.

PLANNERS

Program Chairs
Renée Bullock-Palmer, MD, FASNC – Chair
Wael A. Jaber, MD – Vice-chair

Program Committee
Niti Aggarwal, MD, FASNC
Ahmed Abuzaid, MD
Fares Alahdab, MD, MS
Talal Alnabelsi, MD
Ron Blankstein, MD, FASNC
Paul Cremer, MD, MS
Sarah Cuddy, MD, FASNC
Sharmila Dorbala, MD, MPH, MASNC
Lane Duvall, MD, FASNC
Cesia Gallegos-Kattan, MD
Erika Hutt, MD
Mark Hyun, CNMT, NCT, RT(N)(R), FASNC
Bruno Lima, MD, PhD
Maria Mackin, CNMT, MS, RT(N), FASNC
Ahmad Masri, MD
Manuel Morlote, MD
Venkatesh Murthy, MD, PhD, FASNC
Mike Osborne, MD, FASNC
Krishna Patel, MD, MSc
Ibrahim Saeed, MD, FASNC
Maria Sciammarella, MD
Nishant Shah, MD, MPH, FASNC
Mrinali Shetty, MD
Vasvi Singh, MD, FASNC
Brett W. Sperry, MD
Suman Tandon, MD, FASNC
Gregory Thomas, MD, MPH, MASNC
Sneha Vakamudi, MD
Jaime Warren, Ed.D., MBA, BHS, CNMT, NCT
Richard Weinberg, MD, PhD, FASNC
David Winchester, MD, FASNC

FACULTY/PLANNER/PRESENTER DISCLOSURES

The following individuals have stated that they have no financial relationships with any ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing products used by or own patients, including computer software/hardware, related to the content of the educational presentation in which they are involved:

Abadie, Bryan
Abuzaid, Ahmed
Al Badarin, Firas
Al Rifai, Mahmoud
Alahdab, Fares
Alnabelsi, Talal
Azevedo Junior, Giovane
Bhattaru, Abhijit
Bois, John
Bravo, Paco
Bullock-Palmer, Renée
Campisi, Roxana
Choi, Nu R
Cremer, Paul
Dai, Neng
Dam, Hung
Dobrolinska, Magdalena
Dunn, Timothy
Duran, Jessica
Feher, Attila
Gu, Yufan
Hendel, Robert
Horgan, Stephen
Hulten, Edward
Hutt, Erika
Kaufmann, Julian
Kazerooni, Ella
Keating, Friederike
Khan, Dikhra
Kuronuma, Keiichiro
Kusmirek, Joanna
Lima, Bruno
Lopes, Rafael
Mackin, Maria
Madamanchi, Chaitanya
Mannarino, Teresa
Massalha, Samia
Michael, Jennifer
Neishabouri, Afarin
Nieves, Ricardo
Packard, René
Patel, Amit
Peix Gonzalez, Amalia
Pizzi, María
Polk, Donna
Power, Thomas
Rodriguez Lozano, Patricia
Romero Pabon, Ardel
Saad, Jean Michel
Saeed, Ibrahim
Sagar, Sambit
Sanghani, Rupa
Saunders, Emma
Schockling, Eric
Scordia, Patricia
Sterling, Russell
Stevens, Erin
Tandon, Suman
Taqueti, Viviany
Thompson, Randall
Tilak, Aman
Trivedi, Siddharth
Van Decker, William
Vasilakis, Georgia
Wall, Jonathan
Warren, Jaime
Weinberg, Richard
Williams, Kim
Winchester, David
Zhang, Wenhao

The following individuals have provided financial relationships with ineligible company whose primary business is producing, marketing, selling, re-selling, or distributing products used by or own patients, including computer software/hardware, related to the content of the educational presentation in which they are involved:

Aggarwal, Niti –  Honoraria; Elsevier
Akincioglu, Cigdem –  Research/Grant or Contractor; Pfizer. Honoraria; Canadian Association of Nuclear Medicine.
Al-Mallah, Mouaz –  Research/Grant or Contractor; Siemens. Speakers' Bureau; Jubilant, Pizer.
Ananthasubramaniam, Karthikeyan –  Research/Grant or Contractor; Astellas Pharma UC Inc. Advisory Panel; Alnylam Pharmaceuticals. Research/Grant or Contractor; Ionis Pharmaceuticals, Bristol Myers Squibb. Speakers’ Bureau; Bristol Myers Squibb.
Arumugam, Parthiban –  Speakers’ Bureau; Blue Earth Diagnostics.
Bateman, Timothy –  Research/Grant or Contractor; GEHC, SpectrumDynamics. *Salaried Employee or Owner; CVIT (software). Intellectual property rights; Imagen Software. Advisory Board; GEHC, Synektik.
Benz, Dominik –  Research/Grant or Contractor; Astra Zeneca. Consulting Fee; Pfizer.
Bokhari, Sabahat –  Research/Grant or Contractor; Alnylam. Speakers' Bureau; AstraZeneca, Pfizer, Alnylam. Advisory Board; Biobridge, Alnylam, Pfizer.
Bourque, Jamieson –  Consulting Fee; GE Healthcare.
Case, James –  Owner; CVIT. Grant; Bracco. Consultant and Grant; GE. Grant; Spectrum Dynamics.
Castano, Adam –  *Stock Interest (stocks, stock options or other ownership interest, excluding diversified mutual funds); BridgeBio Pharma. *Salaried Employee or Owner; BridgeBio Pharma.]Chareonthaitawee, Panithaya –  Consulting; Clario. Consulting, Speakers’ fees; Ionetix. Royalties; UpToDate.
Chow, Benjamin –  Research/Grant or Contractor; Artyra, TD Bank. Consulting Fee; Artrya.
Clerc, Olivier –  Research/Grant or Contractor; Research fellowship from the International Society of Amyloidosis and Pfizer.
Cuddy, Sarah –  Advisory Board; Novo Nordisk, BridgeBio. Advisory Board, Research/Grant or Contractor; Ionis, Astra Zeneca, Alexion. Advisory Board, Research/Grant or Contractor; Astra Zeneca. Research/Grant or Contractor; Alnylam. Honoraria; Pfizer.
Di Carli, Marcelo –  Research/Grant or Contractor; Gilead Sciences, Sun Pharma. Consulting Fee; Sanofi, Valo Health, MedTrace.
Dilsizian, Vasken –  Consulting Fee; CDL Nuclear, GE Healthcare.
Dorbala, Sharmila –  Research/Grant or Contractor; Pfizer, Attralus, Siemens, Philips. Consulting Fee; Company/Organization; Pfizer, Novo Nordisk, Medscape.
Druz, Regina –  Consulting Fee; Boston Heart Diagnostics. *Salaried Employee or Owner; Holistic Heart Centers. Intellectual property rights; Holistic Heart Centers.
Einstein, Andrew –  Research/Grant or Contractor; Attralus, BridgeBio, Canon Medical Systems USA, GE HealthCare, Intellia Therapeutics, Ionis Pharmaceuticals, Neovasc, Pfizer, Roche Medical Systems, and W. L. Gore & Associates. Consulting Fee; Artrya. Royalty; Wolters Kluwer Healthcare—UpToDate. Advisory Board; Canon Medical Systems USA.
Ferencik, Maros –  Research/Grant or Contractor; NIH, AHA. Consulting Fee; HeartFlow, Elucid, Siemens Healthineers, BioMarin. *Stock Interest (stocks, stock options or other ownership interest, excluding diversified mutual funds); Elucid. Advisory Board; Cleerly.
Gallegos Kattán, Cesia –  Advisory Board; Pfizer.
Gropler, Robert –  Research/Grant or Contractor; NIH, AHA EIC, Leducq Foundation. Consulting Fee; AHA.
Hyafil, Fabien –  Consulting Fee; Curium Pharma, GE Healthcare, Pfizer. *Stock Interest (stocks, stock options or other ownership interest, excluding diversified mutual funds); Naogen Pharma. Speakers’ Bureau; Curium Pharma, GE Healthcare, Naogen Pharma, Pfizer.
Hyun, Mark –  Consulting Fee; Astellas.
Jaber, Wael –  Research/Grant or Contractor; Boston scientific Institutional CoreLab work, Edwards Institutional CoreLab work, BMS institutional Corelab work. Consulting Fee; Boston Scientific, Pfizer, BioBridge. Honoraria; Pfizer. Advisory Board; Boston Scientific.
Jang, Sun-Joo –  Research/Grant or Contractor; NIH, 5T32HL098069-13. 
Kadoya, Yoshito –  Speaker; Abbott Medical Japan.
Liu, Chi –  Research/Grant or Contractor; Siemens Healthineers, ImaginAb.
Malhotra, Saurabh –  Speakers’ Bureau; AstraZeneca. Speakers’ Bureau and Consultant; Alnylam, Pfizer, Inc. Consultant; Viz.ai.
Masri, Ahmad –  Research/Grant or Contractor; Pfizer, Cytokinetics, Attralus, Ionis. Consulting Fee; Cytokinetics, BMS, Eidos/BridgeBio, Pfizer, Ionis, Lexicon, Attralus, Alnylam, Haya, Alexion, Akros, Prothena, BioMarin, AstraZeneca and Tenaya.
Mesquita, Claudio –  Research/Grant or Contractor; Alnylam, Alexion pharmaceuticals. Speakers' Bureau; Servier, Pfizer, Eckert Ziegler.
Miller, Robert –  Research/Grant or Contractor; Pfizer. Consulting Fee; Pfizer.
Mohammed, Selma –  Other financial benefit; Clinical trial enrollment: Site PI ALLEVIATE-HF sponsored by Medtronic and Site PI DAPA ACT HF-TIMI 68 sponsored by AstraZeneca.
Murthy, Venkatesh –  Research/Grant or Contractor; Siemens. Consulting Fee; INVIA. *Stock Interest (stocks, stock options or other ownership interest, excluding diversified mutual funds); General Electric, Cardinal Health, Ionetix. Advisory Board; Ionetix.
Osborne, Michael –  Research/Grant or Contractor; NIH, AHA. Consulting Fee; WCG Imaging.
Patel, Krishna –  Research grant to institution; Jubilant DraxImage.
Pelletier-Galarneau, Matthieu –  Research/Grant or Contractor; Jubilant Radiopharma.
Phillips, Lawrence –  Consulting Fee; Novo Nordisk.
Schenone, Aldo –  Research/Grant or Contractor; Bristol Myers Squibb. Speakers' Bureau; Bristol Myers Squibb.
Sciammarella, Maria –  *Salaried employee or owner - DynaMed Plus/Ebsco (employee as cardiology section editor 10% of time).
Shah, Nishant –  Research/Grant or Contractor; Pfizer, Inc. Advisory Board; Pfizer, Inc., AstraZeneca.
Singh, Vasvi –  Research/Grant or Contractor; ASNC/Pfizer. Speakers' Bureau; Pfizer, Astra Zeneca.
Slomka, Piotr –  Research/Grant or Contractor; Siemens Medical Systems. Consulting Fee; Synektik, SA. Speakers' Bureau; IBA. Royalty; Cedars-Sinai.
Sperry, Brett –  Research/Grant or Contractor; Pfizer. Consulting Fee; Alnylam, BridgeBio, AstraZeneca. Speakers' Bureau; Pfizer, AstraZeneca.
Thomas, Gregory –  *Salaried Employee or Owner; MemorialCare, Long Beach Medical Center.
Vakamudi, Sneha –  Speakers' Bureau; Abbott Cardiovascular.
Weber, Brittany –  Advisory Board; Novo Nordisk, Horizon, Kiniksa.
Wei, Janet –  Consulting Fee; Abbott Vascular, paid to institution.
Witteles, Ronald –  Consultant; Pfizer, Alnylam, Astra Zeneca, Alexion, BridgeBio, Novo Nordisk. Advisory Board; Pfizer, Alnylam, Astra Zeneca, Alexion, BridgeBio, Novo Nordisk.

Release Date: September 16, 2024
CME Expiration Date: September 15, 2025*
Course Expiration Date: September 15, 2026

*CME must be claimed by this date.

This activity has no commercial support. 

American Society of Nuclear Cardiology 
10300 Eaton Place, Suite 301
Fairfax, VA  22030 
703-459-2555 | info@asnc.org | www.ASNC.org